Effects of γ-aminobutyric acid (GABA) agonists and GABA uptake inhibitors on pharmacosensitive and pharmacoresistant epileptiform activity in vitro

British Journal of Pharmacology

Volumn 119, Issue 3, 1996, Pages 569-577

  Pfeiffer, Michael ^a   Draguhn, Andreas ^a   Meierkord, Hartmut ^a   Heinemann, Uwe ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Entorhinal cortex; Epilepsy; Hippocampus; Nipecotic acid; Seizure like events; Tiagabine; alanine; aminobutyric acid (GABA) uptake

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; BACLOFEN; BETA ALANINE; MAGNESIUM ION; MUSCIMOL; NIPECOTIC ACID; TIAGABINE;

4 AMINOBUTYRIC ACID UPTAKE; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; ENTORHINAL CORTEX; EPILEPTIC DISCHARGE; FEMALE; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029836285     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15710.x     Document Type: Article

References (52)

1. ATTWELL, D., BARBOUR, B. & SZATKOWSKI, M. (1993). Non-vesicular release of neurotransmitter. Neuron, 11, 401-407.
2. BEN-MENACHEM, E. (1995). Vigabatrin. Epilepsia, 36 Suppl. 2, S95-S104.
3. BORDEN, L.A., DHAR, T.G.M., SMITH, K.E., WEINSHANK, R.L., BRANCHEK, T.A. & GLUCHOWSKI, C. (1994). Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur. J. Pharmacol. Mol. Pharmacol., 269, 219-224.
4. BORDEN, L.A., SMITH, K.E., HARTIG, P.R., BRANCHEK, L.A., A WEINSHANK, R.L. (1992) Molecular heterogeneity of the - aminobutyric acid (GABA) transport system. Cloning of two novel high affinity GABA transporter from the brain. J. Biol. Chem., 267, 21098-21104.
5. BUCHANAN, N. (1993). Vigabatrin in drug resistant epilepsy. Mol. J. Aust., 159, 356.
6. CAMMACK, J.N., RAKHILIN, S.V. & SCHWARTZ, E.A. (1994). A GABA transporter operates asymmetrically and with variable stoichiometry. Neuron, 13, 949-960.
7. CLARK, J.A., DEUTCH, A.Y., GALLIPOLI, P.Z. & AMARA, S.G. (1992). Functional expression and CNS distribution of a β-alanine-sensitive neuronal GABA transporter. Neuron, 9, 337-348.
8. DINGLEDINE, R. & KORN, S.J. (1985). γ-Aminobutyric acid uptake and the termination of inhibitory synaptic potentials in the rat hippocampal slice. J. Physiol., 366, 387-409.
9. DREIER, J.P. & HEINEMANN, U. (1990). Late low magnesium-induced epileptiform activity in rat entorhinal cortex slices becomes insensitive to the anticonvulsant valproic acid. Neurosci. Lett., 119, 68-70.
10. DURING, M.J., RYDER, K.M. & SPENCER, D.D. (1995). Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature, 376, 174-177.
11. FINK JENSEN, A., SUZDAK, P.D., SWEDBERG, M.D., JUDGE, M.E., HANSEN, L. & NIELSEN, P.G. (1992). The γ-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats. Eur. J. Pharmacol., 220, 197-201.
12. GONSALVES, S.F., TWITCHELL, B., HARBAUGH, R.E., KROGSGAARD-LARSEN, P. & SCHOUSBOE, A. (1989). Anticonvulsant activity of the glial GABA uptake inhibitor, THAO, in chemical seizures. Eur. J. Pharmacol., 168, 265-268.
13. GRAM, L. (1994). Tiagabine: a novel drug with a GABAergic mechanism of action. Epilepsia, 35 Suppl 5, S85-S87.
14. GUASTELLA, J., NELSON, N., NELSON, H., CZYZYK, L., KEYNAN, S., MIEDEL, M.C., DAVIDSON, N., LESTER, H.A. & KANNER, B.I. (1990). Cloning and expression of a rat brain GABA transporter. Science, 249, 1303-1306.
15. HALONEN, T., MIETTINEN, R., TOPPINEN, A., TUUNANEN, J., KOTTI, T. & RIEKKINEN, P.J. (1995). Vigabatrin protects against kainic acid-induced neuronal damage in the rat hippocampus. Neurosci. Lett., 195, 1316.
16. HEINEMANN, U., DREIER, J., LESCHINGER, A., STABEL, J., DRAGUHN, A. & ZHANG, C. (1994). Effects of anticonvulsant drugs on hippocampal neurons. Hippocampus, 4, 291-296.
17. HEIT, M.C. & SCHWARK, W.S. (1988). Pharmacological studies with a GABA uptake inhibitor in rats with kindled seizures in the amygdala. Neuropharmacology, 27, 367-374.
18. HERRON, C.E., WILLIAMSON, R. & COLLINGRIDGE, G.L. (1985). A selective N-methyl-D-aspartate antagonist depresses epileptiform activity in rat hippocampal slices. Neurosci. Lett., 61, 255-260.
19. HONMOU, O., KOCSIS, J.D. & RICHERSON, G.B. (1995). Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neurons in vitro. Epilepsy Res., 20, 193-202.
20. IKEGAKI, N., SAITO, N., HASHIMA, M. & TANAKA, C. (1994). Production of specific antibodies against GABA transporter subtypes (GAT1, GAT2, GAT3) and their application to immunocytochemistry. Mol. Brain Res., 26, 47-54.
21. ISAACSON, J.S., SOLÍS, J.M. & NICOLL, R.A. (1993). Local and diffuse synaptic actions of GABA in the hippocampus. Neuron, 10, 165-175.
22. JANJUA, N.A., MORI, A. & HIRAMATSU, M. (1991). γ-Aminobutyric acid uptake is decreased in the hippocampus in a genetic model of human temporal lobe epilepsy. Epilepsy Res., 8, 71-74.
23. JAROLIMEK, W., DEMMELHUBER, J., BIJAK, M. & MISGELD, U. (1993). CGP 55845A blocks baclofen, gamma-aminobutyric acid and inhibitory postsynaptic potassium currents in guinea pig CA3 neurons. Neurosci. Lett., 154, 31-34.
24. JONES, R.S.G. (1988). Epileptiform events induced by GABA-antagonists in entorhinal cortical cells in vitro are partly mediated by N-methyl-D-aspartate receptors. Brain Res., 457, 113-121.
25. JONES, R.S.G. (1989). Ictal epileptiform events induced by removal of extracellular magnesium in slices of entorhinal cortex are blocked by baclofen. Exp. Neurol., 104, 155-161.
26. JONES, R.S.G. (1994). GABAergic modification of 4-aminopyridine-induced epileptiform activity in the rat entorhinal cortex. Br. J. Pharmacol., 94, 262P.
27. JONES, R.S.G. & LAMBERT, J.D.C. (1990). Synchronous discharges in the rat entorhinal cortex in vitro: site of initiation and the role of excitatory amino acid receptors. Neuroscience, 34, 657-670.
28. LIU, Q.-R., LÓPEZ-CORCUERA, B., MANDIYAN, S., NELSON, H. & NELSON, N. (1993). Molecular characterization of four pharmacologically distinct γ-aminobutyric acid transporters in mouse brain. J. Biol. Chem., 268, 2106-2112.
29. MACDONALD, R.L. & MCLEAN, M.J. (1986). Anticonvulsant drugs: mechanisms of action. In Advances in Neurology/Basic Mechanisms of the Epilepsies, ed. Delgado-Escueta, A.V., Ward, A.A., Woodbury, D.M. & Porter, R.J. pp. 713-736. New York: Raven Press.
30. MODY, I., DE KONINCK, Y., OTIS, T.S. & SOLTESZ, I. (1994). Bridging the cleft at GABA synapses in the brain. Trends Neurosci., 17, 517-525.
31. MODY, I., LAMBERT, J.D.C. & HEINEMANN, U. (1987). Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J. Neurophysiol., 57, 869-888.
32. MÜLLER, W., MISGELD, U. & HEINEMANN, U. (1988). Carbachol effects on hippocampal neurons in vitro: dependence on the rate of rise of carbachol tissue concentration. Exp. Brain Res., 72, 287-298.
33. OH, D.J. & DICHTER, M.A. (1994). Effect of a γ-aminobutyric acid uptake inhibitor. NNC-711, on spontaneous postsynaptic currents in cultured rat hippocampal neurons: Implications for antiepileptic drug development. Epilepsia, 35, 426-430.
34. 1H spectroscopic measurements of γ-aminobutyric acid, glutamate, and glutamine in human brain. Epilepsia, 36, 457-464.
35. REKLING, J.C., JAHNSEN, H. & MOSFELDT LAURSEN, A. (1990). The effect of two lipophilic γ-aminobutyric acid uptake blockers in CA1 of the rat hippocampal slice. Br. J. Pharmacol., 99, 103-106.
36. RICHENS, A., CHADWICK, D.W., DUNCAN, J.S., DAM, M., GRAM, L., MIKKELSEN, M., MORROW, J., MENGEL, H., SHU, V., MCKELVY, J.F. & PIERCE, M.W. (1995). Adjunctive treatment of partial seizures with tiagabine: A placebo-controlled trial. Epilepsy Res., 21, 37-42.
37. ROEPSTORFF, A. & LAMBERT, J.D.C. (1994). Factors contributing to the decay of the stimulus-evoked IPSC in rat hippocampal CA1 neurons. J. Neurophysiol., 72, 2911-2926.
38. SAYIN, U., TIMMERMAN, W. & WESTERINK, B.H.C. (1995). The significance of extracellular GABA in the substantia nigra of the rat during seizures and anticonvulsant treatments. Brain Res., 669, 67-72.
39. SCHOUSBOE, A. (1982). Transport and metabolism of glutamate and GABA in neurons and glial cells. Int. Rev. Neurobiol., 22, 1-45.
40. SCHOUSBOE, A., LARSSON, O.M., WOOD, J.D. & KROGSGAARD-LARSEN, P. (1983). Transport and metabolism of γ-aminobutyric acid in neurons and glia: implications for epilepsy. Epilepsia. 24, 531-538.
41. SMITH, S.E., PARVEZ, N.S., CHAPMAN, A.G. & MELDRUM, B.S. (1995). The γ-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy. Eur. J. Pharmacol., 273, 259-265.
42. SOLIS, J.M. & NICOLL, R.A. (1992). Postsynaptic action of endogenous GABA released by nipecotic acid in the hippocampus. Neurosci. Lett., 147, 16-20.
43. STANTON, P.K., JONES, R.S.G., MODY, I. & HEINEMANN, U. (1987). Epileptiform activity induced by lowering extracellular [Mg + +] in combined hippocampal-entorhinal cortex slices: modulation by receptors for norepinephrine and N-methyl-D-aspartate. Epilepsy Res., 1, 53-62.
44. SUZDAK, P.D. (1994). Lack of tolerance to the anticonvulsant effects of tiagabine following chronic (21 day) treatment. Epilepsy Res., 19, 205-213.
45. SUZDAK, P.D. & JANSEN, J.A. (1995). A review of the preclinical pharmacology of tiagabine: A potent and selective anticonvulsant GABA uptake inhibitor. Epilepsia. 36, 612-626.
46. THOMPSON, S.M. & GÄHWILER, B.H. (1992). Effects of the GABA uptake inhibitor tiagabine on inhibitory synaptic potentials in rat hippocampal slice cultures. J. Neurophysiol., 67, 1698-1701.
47. WALTHER, H., LAMBERT, J.D.C., JONES, R.S.G., HEINEMANN, U. & HAMON, B. (1986). Epileptiform activity in combined slices of the hippocampus, subiculum and entorhinal cortex during perfusion with low magnesium medium. Neurosci. Lett., 69, 156-161.
48. WALTON, N.Y., GUNAWAN, S. & TREIMAN, D.M. (1994). Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine. Epilepsy Res., 19, 237-244.
49. WHITTINGTON, M.A. & JEFFERYS, J.G.R. (1994). Epileptic activity outlasts disinhibition after intrahippocampal tetanus toxin in the rat. J. Physiol., 481, 593-604.
50. YLINEN, A.M.A., MIETTINEN, R., PITKÄNEN, A., GULYAS, A.I., FREUND, T.F. & RIEKKINEN, P.J. (1991). Enhanced GABAergic inhibition preserves hippocampal structure and function in a model of epilepsy. Proc. Natl. Acad. Sci. U.S.A., 88, 7650-7653.
51. ZHANG, C.L., DREIER, J.P. & HEINEMANN, U. (1995). Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants. Epilepsy Res., 20, 105-111.
52. ZHANG, C.L., GLOVELI, T. & HEINEMANN, U. (1994). Effects of NMDA- and AMPA-receptor antagonists on different forms of epileptiform activity in rat temporal cortex slices. Epilepsia, 35 Suppl. 5, S68-S73.